Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Molson Coors (TAP) trades at deeply discounted multiples and throws off strong free cash flow and a chunky dividend, yet it faces a secular beer-volume decline, material leverage and uneven recent results. This trade idea is a cautious, mid-term long that treats the stock as a value rebound candidate rather than a buy-and-forget income play.
Residents of Havana are confronting widespread power failures and prolonged water outages that have contributed to viral and diarrheal illnesses. The city's reliance on electric pumps and recent US-imposed fuel restrictions have intensified blackouts, impairing refrigeration and water distribution for millions. Health authorities in Cuba and a rece…
Ocugen, Inc. announced its participation in several upcoming scientific conferences where it will present its novel modifier gene therapy platform targeting blindness diseases such as geographic atrophy, Stargardt disease, and retinitis pigmentosa. The company aims to demonstrate progress from multiple clinical trials including Phase 1/2 and Phase …
Tiziana Life Sciences announced the submission of an Orphan Drug Designation request to the FDA for intranasal foralumab, an immunomodulatory therapy aimed at treating Multiple System Atrophy (MSA). This designation would provide regulatory benefits including market exclusivity and tax credits, supporting advancement of this novel treatment. The co…
ACM Research, Inc., a Nasdaq-listed semiconductor equipment supplier, announced that its operating subsidiary, ACM Research (Shanghai), reported a significant increase in backlog as of September 29, 2026. The backlog reached RMB 17.1 billion (approximately USD $2.5 billion), marking an 88.2% rise compared to the previous year. The backlog includes …
Rafael Holdings announced topline results from its pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C (NPC). While the primary endpoint did not reach statistical significance in the overall population, a prespecified subgroup receiving background miglustat and/or leucine therapy (83% of patients) showed …
Ambow Education Holding Ltd. (NYSE American: AMBO) has introduced HybriU Events On Demand, a portable, AI-driven hybrid event system delivered in a single transport case, enabling venues to host professional 2D/3D live broadcasts, real-time interpretation in 65+ languages, recording, and AI knowledge capture without permanent installation or equipm…
GDEV Inc. announced the final results of its cash tender offer to repurchase up to $20 million of its ordinary shares at $11.03 per share. Only 57,110 shares (approximately 0.3% of total shares) were tendered and purchased, costing about $630,000. The repurchased shares will be held as treasury stock for potential future issuance. This buyback repr…
NRx Pharmaceuticals' subsidiary, NRx Defense Systems, received an $11.18 million contract from DARPA to conduct the SPARC-TMS clinical trial evaluating a novel one-day robotic transcranial magnetic stimulation (TMS) protocol augmented with their investigational drug NRX-101 for treatment resistant depression. The trial, conducted at prestigious ins…
Adlai Nortye, a clinical-stage biotechnology company listed on NASDAQ, has appointed Christopher Liu, PharmD, an equity research veteran specializing in biotechnology and oncology, as its new Head of Investor Relations and Public Relations. This strategic hire aims to strengthen engagement with the global investment community and improve the commun…
Beamr Imaging Ltd. announced a three-year renewal of its license agreement with a major global streaming platform extending through 2029, resulting in an expected 50% increase in fiscal year 2026 revenues to approximately $4.5 million. The company highlights sustainable demand for its video optimization technology and anticipates continued growth i…
Ceribell, Inc. has received FDA 510(k) clearance for new software updates to its Ceribell System that simplify interpretation of EEG data. These updates include features such as Alpha-Delta Ratio and Relative Alpha Trending, Burst Suppression monitoring, and Amplitude-Integrated EEG analysis, enabling faster and easier brain monitoring in critical …
Harrow, Inc. announced that fifteen scientific abstracts highlighting clinical data from its ophthalmic product portfolio will be presented at the 2026 American Academy of Optometry and American Academy of Ophthalmology meetings. The research spans multiple eye conditions, including dry eye disease, vernal keratoconjunctivitis, ocular inflammation,…
Sono-Tek Corporation announced it received three purchase orders totaling $7.19 million from an existing clean energy sector customer, marking the largest order in the company's history. These orders consist of 10 production-scale ultrasonic coating systems to be delivered primarily in fiscal 2028, significantly increasing revenue visibility. Along…
Kailera Therapeutics announced the completion of enrollment in its KaiNETIC global Phase 3 clinical program evaluating ribupatide injection, a dual GLP-1/GIP receptor agonist, for obesity treatment. The program includes three trials with topline data expected by mid-2028. Ribupatide aims to provide a once-weekly injectable treatment addressing unme…
Tilray Brands’ 10 Barrel Brewing introduces the Salty Sips Blackberry Refresher, a low-sugar, vodka-based ready-to-drink cocktail featuring real blackberry juice and sea salt. Following the successful launch of the Watermelon Refresher, this new flavor aims to cater to consumers seeking flavorful, balanced, and easy-drinking options. Initially avai…
Satellos Bioscience Inc. announced the successful completion of enrollment for the BASECAMP Phase 2 clinical trial evaluating their oral small molecule drug candidate forazapadin for treating Duchenne muscular dystrophy (DMD) in ambulatory boys aged 7 to 10. The trial, conducted globally across multiple sites, will assess safety, tolerability, and …
FactSet reported its fourth quarter and full fiscal 2026 financial results, highlighting a 7.0% increase in organic Annual Subscription Value (ASV), 6.7% revenue growth, and robust AI solution adoption which more than doubled year-over-year. The company maintained strong subscription retention and returned significant capital to shareholders throug…
GlobalFoundries announced the date for its third quarter 2026 financial results conference call, which will be held on November 4, 2026. The company highlighted its role as a leading manufacturer of semiconductors powering AI and various high-growth sectors. The call aims to provide insights into the company’s financial performance and operational …
Nexera Technologies’ majority-owned subsidiary Fort Technology has acquired a 50.1% interest in Logia USA, which holds an exclusive U.S. license for automated fuel-integrity systems developed by Logia Israel. This acquisition positions Fort to commercialize fuel maintenance solutions for standby generators in the growing U.S. data center market, pr…
Alamos Gold Inc., a Canadian-based intermediate gold producer listed on both the TSX and NYSE, plans to release its third quarter 2026 financial results after market close on October 28, 2026, followed by a management conference call on October 29, 2026. The company operates multiple mining sites in North America and continues to develop growth pro…
ANI Pharmaceuticals announced the presentation of new data from its Phase 4 SYNCHRONICITY trial on Fluocinolone Acetonide Intravitreal Implant for chronic non-infectious uveitis at the American Academy of Ophthalmology 2026 meeting. The data include six-month topline results and post-hoc analyses from the NEW DAY trial for diabetic macular edema. T…
Descartes Systems Group announced that it will showcase cutting-edge AI and logistics technology innovations designed to streamline supply chain operations at its 2026 Innovation Forum in Chicago. The technologies include AI-driven transportation management, fleet performance optimization, global trade intelligence, and ecommerce operations enhance…
Seanergy Maritime trades at a modest $355M market cap with a P/E of 5.7 and a 3.5% yield. The company’s Capesize-heavy fleet, shareholder-friendly payout, and a shallow float make the stock an asymmetric risk-reward. We rate SHIP Strong Buy and lay out an entry at $16.61, stop at $13.50 and a $24.00 target.
Zoetis is trading near its 52-week low after a string of execution concerns and legal headlines. With a market cap near $29B, EV/EBITDA ~9.0 and free cash flow of $2.37B, the stock offers a compelling risk/reward if you buy with discipline. This trade idea lays out an actionable entry at $70.50, a stop at $63.00, and a long-term target of $110.00, …
